Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Ipilimumab × 30 days × Clear all

Phase

Status

Active not recruiting 28 Recruiting 20 Completed 8 Not yet recruiting 3 Suspended 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Melanoma 1

Interventions

pembrolizumab 10 Nivolumab 7 Carboplatin 6 Specimen Handling 5 Pemetrexed 5 Interviews as Topic 5 Biopsy 5 venetoclax 4 durvalumab 4 X-Rays 4 Paclitaxel 4 Magnetic Resonance Spectroscopy 4 Drug Therapy 4 olaparib 3 fludarabine 3 binimetinib 3 Surveys and Questionnaires 3 Radiosurgery 3 Gemcitabine 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 toripalimab 2 tislelizumab 2 spartalizumab 2 regorafenib 2 ibrutinib 2 encorafenib 2 atezolizumab 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05926960 2026-03-09

PORTSIDE

Pfizer

Phase 2 Terminated

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡